Vera Therapeutics

Business Services · California, United States · 51 Employees

View Company Info for Free

About

Headquarters

8000 Marina Blvd Ste 120, Brisbane, California,...

Phone Number

(650) 770-0077

Website

www.veratx.com

Revenue

$117.2 Million

Stock Symbol

VERA

Industry

Business Services General

Business Services

Most Recent Scoops

Sep 10 2024

Open Position

Sep 3 2024

Open Position

Vera Therapeutics is currently seeking a Sb Nation Director, Network Development. (Jordan)

See all scoops

Highlights

$97M

Total Funding Amount

$80M

Most Recent Funding Amount

Number of Funding Rounds

View details

Who is Vera Therapeutics

Vera Therapeutics is a clinical-stage biotechnology company focused on developing treatments for immunological diseases that improve patients' live s. Vera's lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator (BLyS) and a proliferation-inducing ligand (APRIL), which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases. In addition, Vera is evaluating additional diseases where the reduction of autoantibodies by atacicept may prove medically useful, including lupus nephritis, a severe renal manifestation of systemic lupus erythematosus.Read more

Is this data correct?

View contact profiles from Vera Therapeutics

Popular SearchesVera Therapeutics IncAimmune Therapeutics IncAimmune TherapeuticsAimmuneVera TherapeuticsSIC Code 87,873NAICS Code 54,541Ticker NASDAQ: VERAShow more

Vera Therapeutics Org Chart

Phone

Amit Sharma

Executive Vice President

Phone

Is Vera Therapeutics your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Last 7 days

Earning: See what the market has to say on Vera Therapeutics recently announced quarterly report

Website visits: Recent activity has been detected on your website

Vera Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic

Check if Vera Therapeutics has recently received funding, and reach out quickly before it becomes old news!

Competitive Alert! Recent activity has been detected by your competitor Masked Content

Check out if Vera Therapeutics is spiking on competitors!

Funding: Get notified immidiatlly once Vera Therapeutics has new funding data

Product Launch: Get notified when Vera Therapeutics launches new products

Click to see if Vera Therapeutics had a recent Job posting/layoffs

Congratulate Masked Content for being promoted to Masked Content at Vera Therapeutics

Recommended Actions

Find VP level buyers at Vera Therapeutics

Find more new buyers

Similar Companies to Vera Therapeutics

Analyze insights from companies similar to Vera Therapeutics and make strategic comparisons based on performance, financial data, growth and unique benchmarks.

See more companies

View Email Formats for Vera Therapeutics

Vera Therapeutics financials insights

Gather financial insights about Vera Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

Graph showing recent funding, most recent acquisition, and main investor information for Vera Therapeutics.

See All Financials Insights

Vera Therapeutics Employee Growth Rate

Graph showing projected employee growth data for Vera Therapeutics

View Vera Therapeutics’s full employee growth data

Percentage of growth

1st year Mask

2nd year Mask

Vera Therapeutics Tech Stack

A closer look at the technologies used by Vera Therapeutics

PHP

See more technologies

Most Recent Scoops

Sep 10 2024

Open Position

Sep 10 2024

Open Position

Sep 3 2024

Open Position

Vera Therapeutics is currently seeking a Sb Nation Director, Network Development. (Jordan)

Sep 3 2024

Open Position

Vera Therapeutics is currently seeking a SAP Attp Hana Principal Architect & Associate Director, Projects. (Gdańsk, Poland)

Aug 31 2024

Open Position

Vera Therapeutics is currently seeking a Sat,td,assistant Director. (Bristol, United Kingdom)

See more scoops

Vera Therapeutics News & Media

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BRISBANE, Calif., Oct. 04, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on October 2, 2024, the Compensation Committee granted inducement awards consisting of a non-qualified stock option to purchase 125,000 shares of Class A common stock and restricted stock units (RSUs) for 62,500 shares of Class A common stock to seven new employees under the Inducement Plan. The Compensation Committee approved the awards as an inducement material to the new
Oct 4, 2024
www.globenewswire.com
Vera Therapeutics Announces Expanded Atacicept Development Program In Multiple Autoimmune Kidney Diseases
BRISBANE, Calif., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced expansion of its development pipeline for its lead asset, atacicept. This program is expected to build on the positive data reported to date from the ongoing ORIGIN Phase 2b and 3 clinical program developing atacicept to treat pat
Oct 2, 2024
www.globenewswire.com
Vera Therapeutics Announces Late-Breaking Oral Presentation of ORIGIN Phase 2b Long-term Results at the American Society of Nephrology Kidney Week 2024
BRISBANE, Calif., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced that long-term results from the ORIGIN Phase 2b clinical trial of atacicept for the treatment of IgAN will be delivered in a late-breaking oral presentation, and two informational posters will describe the ORIGIN Phase 3 and ORIGI
Oct 2, 2024
www.globenewswire.com
Vera Therapeutics to Host In-Person R&D Day in New York to Discuss Potential Indication Expansion for Atacicept on October 2, 2024
BRISBANE, Calif., Sept. 16, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced that it will host an in-person and virtual R&D Day in New York, NY at 8:00 AM ET on Wednesday, October 2, 2024. To register, click here.
Sep 16, 2024
www.globenewswire.com
Vera Therapeutics Completes Enrollment for Primary Endpoint in Pivotal Phase 3 ORIGIN 3 Trial of Atacicept in IgAN
BRISBANE, Calif., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced that it has completed enrollment ahead of schedule for the primary endpoint in the pivotal Phase 3 ORIGIN 3 trial of atacicept in patients with IgAN. The enrollment of 200 participants in this initial cohort of the trial will pro
Sep 12, 2024
www.globenewswire.com

Top Companies in United States

Frequently Asked Questions Regarding Vera Therapeutics

Where is Vera Therapeutics located?

Vera Therapeutics's headquarters are located at 8000 Marina Blvd Ste 120, Brisbane, California, 94005, United States

What is Vera Therapeutics's phone number?

Vera Therapeutics's phone number is (650) 770-0077

What is Vera Therapeutics's stock symbol?

Vera Therapeutics's stock symbol is VERA

What is Vera Therapeutics's official website?

Vera Therapeutics's official website is www.veratx.com

What is Vera Therapeutics's Revenue?

Vera Therapeutics's revenue is $117.2 Million

What is Vera Therapeutics's SIC code?

Vera Therapeutics's SIC: 87,873

What is Vera Therapeutics's NAICS code?

Vera Therapeutics's NAICS: 54,541

How many employees does Vera Therapeutics have?

Vera Therapeutics has 51 employees

What industry does Vera Therapeutics belong to?

Vera Therapeutics is in the industry of: Business Services General, Business Services

What is Vera Therapeutics competition?

Vera Therapeutics top competitors include: Bayhill Therapeutics, Vimelea Therapeutics, ALTuCELL, Cartesian Therapeutics

What technology does Vera Therapeutics use?

Some of the popular technologies that Vera Therapeutics uses are: DocuSign, WordPress.org, Drupal, PHP

How do I contact Vera Therapeutics?

Vera Therapeutics contact info: Phone number: (650) 770-0077 Website: www.veratx.com

What does Vera Therapeutics do?

What are Vera Therapeutics social media links?

Vera Therapeutics Linkedin page Vera Therapeutics Twitter page Vera Therapeutics Facebook page

How much funding has Vera Therapeutics raised to date?

Vera Therapeutics has raised $97 Million in 2 funding rounds

When was the last funding round for Vera Therapeutics?

Vera Therapeutics closed its last funding round on Jan 19, 2021 with the amount of $80 Million

Who invested in Vera Therapeutics?

Vera Therapeutics has 8 investors including Surveyor Capital, Battery Ventures, Amplify Partners and Sutter Hill Ventures.

Is Vera Therapeutics a public company?

Yes, Vera Therapeutics is a public company and is traded under the symbol VERA

See more information about Vera Therapeutics

Vera Therapeutics Latest Hires and Their Positions

Vera Therapeutics is expanding and recently hired new employees. Here are the latest additions to the team.

Renee Gardner

HR Specialist

Joined Aug 1, 2024

Phone

Gursimran Singh

Analyst

Joined Jul 8, 2024

Phone

Raffaella Faggioni

Vice President

Joined Jul 1, 2024

Phone

Amit Sharma

Executive Vice President

Joined Jul 1, 2024

Phone

Sell Smarter. Win Faster.

Level up your game to ZoomInfo Copilot, intuitive AI that turns your data and high-quality ZoomInfo data into an unfair advantage for your go-to-market teams.